We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBARK.L Regulatory News (BARK)

  • There is currently no data for BARK

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major licensing deal for Cambridge Sleep Sciences

6 Jun 2023 07:00

RNS Number : 7237B
Barkby Group PLC
06 June 2023
 

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in accordance with the company's obligations under Article 17 of MAR.

 

 

Barkby Group PLC

 

("Barkby" or the "Company")

 

 

Cambridge Sleep Sciences Announces Major Licensing Deal

 

Barkby (AIM: BARK) announces that its subsidiary, Cambridge Sleep Sciences, ("CSS") the science-based sleep technology business behind SleepHub®, has granted a five-year global license, (the "Agreement") to Sleep Sense International Limited, ("SSI") enabling it to manufacture a Smart Pillow using CSS's SleepEngine® platform.

 

Under the terms of the Agreement SSI holds exclusive rights in the pillow market subject to a Minimum Order Quantity, ("MOQ") of 25,000 units in the first 12 months. CSS will grant a 12-month extension of this exclusivity subject to a MOQ of 60,000 units for year two of the license.

 

Based on these MOQ's, CSS expects the license to generate royalty payments of £1.25 million in the first 12 months and £3.0 million in year two for the Company. MOQs and payments for years three, four and five will be agreed in November 2024.

 

Dr Julian Stone, CEO of CSS, said: 

"We are excited to be working with Sleep Sense International in such a large market. By embedding SleepEngine® we can now deliver our unique audio solution to aid and improve people's sleep through most third-party speakers, headphones and earbuds.

 

"The Agreement changes the market opportunity for us as we move the business towards a Software As A Service business model. We expect this licensing deal to be the first of many for SleepEngine®."

 

Mike Hobson, Managing Director of SSI said:

"We are really excited being partnered with CSS in this exciting new venture in creating the ultimate sleep product. With our experience of manufacturing quality natural sleep products combined with this new technology, developed with CSS, plus our global reach of customers new and old, we know this will change the whole conception of sleep."

 

SleepEngine® technology has been developed and refined over more than a decade by a team of researchers, scientists, sound and medical experts. The result is a unique audio solution that helps to retrain the brain to restore healthy natural sleep patterns, a key component for mental, physical, and cognitive wellbeing. SleepEngine® technology offers a unique integration opportunity with existing or new third-party products capable of delivering high quality audio.

 

SSI is a white label bedding company specialising in helping brands and retailers develop and launch new product propositions within the bedding category. Its brands include, Laura Ashley, Mammoth, Sleepeezee, Pillowheadzzzz, Airsprung, Millbrook and Staingard. 

 

CSS has agreed a separate global license for SleepEngine® with a multinational technology company and will be announcing more details shortly.

 

- Ends -

 

 

For more information

 

Barkby Group plc

Charles Dickson, Executive Chairman

 

c/o Montfort Communications

finnCap Ltd (Nomad and Broker)

Carl Holmes and Simon Hicks (Corporate Finance)

Tim Redfern and Richard Chambers (ECM)

 

+44 (0)20 7220 0500

Montfort

Olly Scott

Georgia Colkin

 

+44 (0)78 1234 5205

 

 

 

About Barkby

 

Barkby is a roadside real estate business focused on building and scaling a high-quality portfolio of modern, ESG-compliant assets. It is in the process of exiting its non-core investments, (comprising Workshop Coffee and Cambridge Sleep Sciences).

 

About Cambridge Sleep Sciences Ltd

Cambridge Sleep Sciences Ltd, part of the Life Sciences division of The Barkby Group Plc, develops technology which improves natural sleep. Using the principles of neuroscience and cutting-edge technology to enhance brain activity during sleep, its innovative solutions aim to improve health, wellbeing and enhance quality of life. 

 

The company prides itself on delivering the first neuroscience-based electronic sleep product, SleepHub®, to help improve and facilitate natural sleep. 

 

Find out more at: www.cambridgesleepsciences.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUDGGDLCDGDGXU
12
Date   Source Headline
30th Jan 20246:03 pmRNSChange of Name to Roadside Real Estate plc
2nd Jan 20247:00 amRNSResult of General Meeting
19th Dec 202311:15 amRNSUpdate on debt refinancing and CSS
15th Dec 20237:00 amRNSFirst joint venture acquisition
13th Dec 20235:39 pmRNSPosting of Circular and Notice of General Meeting
4th Dec 20237:00 amRNSIntention to refinance debt facilities
7th Nov 20237:00 amRNSPractical completion of second Roadside asset
31st Oct 20237:00 amRNSFormation of Roadside Real Estate Joint Venture
29th Sep 20237:00 amRNSTrading update
19th Sep 20237:00 amRNSCSS Announces Licensing Deal with Mammoth
11th Sep 20237:00 amRNSResponse to media speculation re CSS
1st Aug 20237:00 amRNSDisposal of Workshop Coffee
14th Jun 20237:42 amRNSCSS announces new licensing agreement
9th Jun 20237:00 amRNSPub portfolio update
6th Jun 20237:00 amRNSMajor licensing deal for Cambridge Sleep Sciences
31st May 20237:00 amRNSPractical completion of first Roadside asset
15th May 20237:00 amRNSBoard Update, Equity Issue & Total Voting Rights
31st Mar 20237:00 amRNSInterim results
22nd Feb 20235:26 pmRNSResult of AGM
16th Jan 20237:00 amRNSNotice of AGM & Debt Facility Drawing
30th Dec 20227:01 amRNSFinal results for the year ended 2 July 2022
30th Dec 20227:00 amRNSRevised debt facility
28th Nov 20227:00 amRNSTrading and Strategy Update
25th Nov 20227:00 amRNSAcquisition of the Eliot Arms
7th Sep 20225:48 pmRNSHolding(s) in Company
18th Jul 20227:00 amRNSTrading and Strategy Update
21st Jun 20223:19 pmRNSDirector/PDMR Shareholding
11th May 20225:21 pmRNSHolding(s) in Company
26th Apr 20227:00 amRNSExchange of Contracts at Saffron Walden, Essex
1st Apr 20227:00 amRNSAcquisition of The Coach and Horses
30th Mar 20227:20 amRNSInterim Results
4th Mar 20226:09 pmRNSHolding(s) in Company
3rd Mar 20227:00 amRNSAppointment of Group Property Director
2nd Mar 20227:00 amRNSVerso Biosense completes clinical study
1st Mar 20227:00 amRNSBoard Update
8th Feb 20225:35 pmRNSResult of AGM
3rd Feb 20223:33 pmRNSIssue of Equity and Total Voting Rights
25th Jan 20227:00 amRNSCambridge Sleep Sciences Announces New Partners
18th Jan 20227:00 amRNSVerso Biosense study nears completion
13th Jan 20227:00 amRNSPosting of Annual Report & Notice of AGM
24th Dec 20217:00 amRNSFinal Results for the Year Ended 1 July 2021
20th Dec 20212:06 pmRNSSecond Price Monitoring Extn
20th Dec 20212:00 pmRNSPrice Monitoring Extension
17th Dec 20217:00 amRNSExchange of Contracts in Swindon, Wiltshire
27th Oct 20214:41 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20212:05 pmRNSSecond Price Monitoring Extn
27th Oct 20212:00 pmRNSPrice Monitoring Extension
27th Oct 202111:05 amRNSSecond Price Monitoring Extn
27th Oct 202111:00 amRNSPrice Monitoring Extension
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.